JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive: In blast crisis chronic myeloid leukemia (BC CML), JAK2 activation and BCR-ABL1 amplification was shown to increase ADAR1 expression promoting leukemia stem cell (LSC) self-renewal (30).